Specjalistyczny gabinet dermatologiczny Aplikacyjno-Badawczy Marek Brzewski, Paweł Brzewski s.c.

Research site

Poland Ul. Zbożowa 2/25, 30-002, Poland

Hidradenitis · Dermatitis atopic
Adult patients

About Specializations

Specjalistyczny gabinet dermatologiczny Aplikacyjno-Badawczy Marek Brzewski, Paweł Brzewski s.c. in Poland specialises in clinical trials of conditions such as Hidradenitis, Dermatitis atopic, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Ul. Zbożowa 2/2530-002Poland

Open in maps ↗

Recruiting now: no trials
Conditions studied: 2

More sites in Poland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

3 clinical trials

Hidradenitis

Not recruiting

Long-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa

InvestigationalNo placebo

Long-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Sonelokimab
Sponsor:MoonLake Immunotherapeutics AG

Contact Research Centre

Dermatitis atopic

Not recruiting

Study on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Atopic Dermatitis

Investigational

Study on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Atopic Dermatitis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:RO7790121
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Hidradenitis

Not recruiting

Study on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Study on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Sonelokimab
Sponsor:MoonLake Immunotherapeutics AG

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites